Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

por Jacobs, Ira, Petersel, Danielle, Isakov, Leah, Lula, Sadiq, Lea Sewell, K.
Publicado 2016

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthrit...

por Cohen, Stanley B., Alten, Rieke, Kameda, Hideto, Hala, Tomas, Radominski, Sebastiao C., Rehman, Muhammad I., Palaparthy, Ramesh, Schumacher, Karl, Schmitt, Susanne, Hua, Steven Y., Ianos, Claudia, Lea Sewell, K.
Publicado 2018